The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias

Nature Genetics

Volumn 47, Issue 4, 2015, Pages 330-337

  Andersson, Anna K ^a,b   Ma, Jing ^a   Wang, Jianmin ^a   Chen, Xiang ^a   Gedman, Amanda Larson ^a   Dang, Jinjun ^a   Nakitandwe, Joy ^a   Holmfeldt, Linda ^a   Parker, Matthew ^a   Easton, John ^a   Huether, Robert ^a   Kriwacki, Richard ^a   Rusch, Michael ^a   Wu, Gang ^a   Li, Yongjin ^a   Mulder, Heather ^a   Raimondi, Susana ^a   Pounds, Stanley ^a   Kang, Guolian ^a   Shi, Lei ^a   Becksfort, Jared ^a   Gupta, Pankaj ^a   Payne Turner, Debbie ^a   Vadodaria, Bhavin ^a   Boggs, Kristy ^a   Yergeau, Donald ^a   Manne, Jayanthi ^a   Song, Guangchun ^a   Edmonson, Michael ^a   Nagahawatte, Panduka ^a   Wei, Lei ^a   Cheng, Cheng ^a   Pei, Deqing ^a   Sutton, Rosemary ^c   Venn, Nicola C ^d   Chetcuti, Albert ^d   Rush, Amanda ^d   Catchpoole, Daniel ^e   Heldrup, Jesper ^b   Fioretos, Thoas ^f   Lu, Charles ^f   Ding, Li ^a   Pui, Ching Hon ^a   Shurtleff, Sheila ^a   Mullighan, Charles G ^a   Mardis, Elaine R ^f   Wilson, Richard K ^f   Gruber, Tanja A ^a   Zhang, Jinghui ^a   Downing, James R ^a   more..

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; GENOMIC RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; RAS PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN; MLL PROTEIN, HUMAN; ONCOPROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER RECURRENCE; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA SEQUENCE; EPIGENETICS; EXOME; GENE; GENE FREQUENCY; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC ASSOCIATION; GENOME; HUMAN; HUMAN CELL; INFANT; MLL GENE; MUTATION RATE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; RNA SEQUENCE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; ALLELIC IMBALANCE; COHORT ANALYSIS; GENETICS; METABOLISM; MUTATION; NUCLEOTIDE SEQUENCE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

ALLELIC IMBALANCE; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; GENE FREQUENCY; HUMANS; INFANT; MUTATION; MYELOID-LYMPHOID LEUKEMIA PROTEIN; ONCOGENE PROTEINS, FUSION; PHOSPHATIDYLINOSITOL 3-KINASES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTEIN-TYROSINE KINASES; RAS PROTEINS; SIGNAL TRANSDUCTION;

EID: 84925841593     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3230     Document Type: Article

References (68)

1. Pieters, R. et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet 370, 240-250 (2007)
2. Biondi, A., Cimino, G., Pieters, R. & Pui, C.H. Biological and therapeutic aspects of infant leukemia. Blood 96, 24-33 (2000)
3. Pui, C.H. et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N. Engl. J. Med. 360, 2730-2741 (2009)
4. Ford, A.M. et al. In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature 363, 358-360 (1993)
5. Gale, K.B. et al. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc. Natl. Acad. Sci. USA 94, 13950-13954 (1997)
6. Mullighan, C.G. et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446, 758-764 (2007)
7. Bardini, M. et al. Implementation of array based whole-genome high-resolution technologies confirms the absence of secondary copy-number alterations in MLL-AF4-positive infant ALL patients. Leukemia 25, 175-178 (2011)
8. Krivtsov, A.V. & Armstrong, S.A. MLL translocations, histone modifications and leukaemia stem-cell development. Nat. Rev. Cancer 7, 823-833 (2007)
9. Downing, J.R. et al. The Pediatric Cancer Genome Project. Nat. Genet. 44, 619-622 (2012)
10. Wang, J. et al. CREST maps somatic structural variation in cancer genomes with base-pair resolution. Nat. Methods 8, 652-654 (2011)
11. Zhang, J. et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481, 157-163 (2012)
12. Zhang, J. et al. Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat. Genet. 45, 602-612 (2013)
13. Lawrence, M.S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214-218 (2013)
14. Wu, G. et al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat. Genet. 44, 251-253 (2012)
15. Zhang, J. et al. A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature 481, 329-334 (2012)
16. Gillert, E. et al. A DNA damage repair mechanism is involved in the origin of chromosomal translocations t(4;11) in primary leukemic cells. Oncogene 18, 4663-4671 (1999)
17. Reichel, M. et al. Fine structure of translocation breakpoints in leukemic blasts with chromosomal translocation t(4;11): the DNA damage-repair model of translocation. Oncogene 17, 3035-3044 (1998)
18. Super, H.G. et al. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia. Genes Chromosom. Cancer 20, 185-195 (1997)
19. Meyer, C. et al. The MLL recombinome of acute leukemias in 2013. Leukemia 27, 2165-2176 (2013)
20. Downing, J.R. et al. The der(11)-encoded MLL/AF-4 fusion transcript is consistently detected in t(4;11)(q21;q23)-containing acute lymphoblastic leukemia. Blood 83, 330-335 (1994)
21. Zhang, Y. & Rowley, J.D. Chromatin structural elements and chromosomal translocations in leukemia. DNA Repair (Amst.) 5, 1282-1297 (2006)
22. Schubbert, S., Shannon, K. & Bollag, G. Hyperactive Ras in developmental disorders and cancer. Nat. Rev. Cancer 7, 295-308 (2007)
23. Tyner, J.W. et al. High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients. Blood 113, 1749-1755 (2009)
24. Smith, G. et al. Activating K-Ras mutations outwith 'hotspot' codons in sporadic colorectal tumours-implications for personalised cancer medicine. Br. J. Cancer 102, 693-703 (2010)
25. Janakiraman, M. et al. Genomic and biological characterization of exon 4 KRAS mutations in human cancer. Cancer Res. 70, 5901-5911 (2010)
26. Smith, C.C. et al. Activity of ponatinib against clinically-relevant AC220-resistant kinase domain mutants of FLT3-ITD. Blood 121, 3165-3171 (2013)
27. Bentires-Alj, M. et al. Activating mutations of the Noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res. 64, 8816-8820 (2004)
28. Loh, M.L. et al. Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. Blood 103, 2325-2331 (2004)
29. Burke, J.E., Perisic, O., Masson, G.R., Vadas, O. & Williams, R.L. Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110 (PIK3CA). Proc. Natl. Acad. Sci. USA 109, 15259-15264 (2012)
30. Heidel, F. et al. Clinical resistance to the kinase inhibitor PKC412 in acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase domain. Blood 107, 293-300 (2006)
31. von Bubnoff, N. et al. FMS-like tyrosine kinase 3-internal tandem duplication tyrosine kinase inhibitors display a nonoverlapping profile of resistance mutations in vitro. Cancer Res. 69, 3032-3041 (2009)
32. Opatz, S. et al. Exome sequencing identifies recurring FLT3 N676K mutations in core-binding factor leukemia. Blood 122, 1761-1769 (2013)
33. Mullighan, C.G., Williams, R.T., Downing, J.R. & Sherr, C.J. Failure of CDKN2A/B (INK4A/B-ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABL. Genes Dev. 22, 1411-1415 (2008)
34. Filippakopoulos, P. & Knapp, S. Targeting bromodomains: epigenetic readers of lysine acetylation. Nat. Rev. Drug Discov. 13, 337-356 (2014)
35. Heerema, N.A. et al. Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Childrens Cancer Group. Blood 83, 2274-2284 (1994)
36. De Lorenzo, P. et al. Cytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangements. Leukemia 28, 428-430 (2014)
37. Heerema, N.A. et al. Abnormalities of chromosome bands 15q13-15 in childhood acute lymphoblastic leukemia. Cancer 94, 1102-1110 (2002)
38. Sausen, M. et al. Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma. Nat. Genet. 45, 12-17 (2013)
39. Szczepański, T., Harrison, C.J. & van Dongen, J.J. Genetic aberrations in paediatric acute leukaemias and implications for management of patients. Lancet Oncol. 11, 880-889 (2010)
40. Huether, R. et al. The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes. Nat. Commun. 5, 3630 (2014)
41. Dobbins, S.E. et al. The silent mutational landscape of infant MLL-AF4 pro-B acute lymphoblastic leukemia. Genes Chromosom. Cancer 52, 954-960 (2013)
42. Chang, V.Y., Basso, G., Sakamoto, K.M. & Nelson, S.F. Identification of somatic and germline mutations using whole exome sequencing of congenital acute lymphoblastic leukemia. BMC Cancer 13, 55 (2013)
43. Driessen, E.M. et al. Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants. Haematologica 98, 937-944 (2013)
44. Liang, D.C. et al. K-Ras mutations and N-Ras mutations in childhood acute leukemias with or without mixed-lineage leukemia gene rearrangements. Cancer 106, 950-956 (2006)
45. Prelle, C., Bursen, A., Dingermann, T. & Marschalek, R. Secondary mutations in t(4;11) leukemia patients. Leukemia 27, 1425-1427 (2013)
46. Kim, W.I., Matise, I., Diers, M.D. & Largaespada, D.A. RAS oncogene suppression induces apoptosis followed by more differentiated and less myelosuppressive disease upon relapse of acute myeloid leukemia. Blood 113, 1086-1096 (2009)
47. Ono, R. et al. Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce acute leukemia through aberrant Hox expression and Raf activation. Leukemia 23, 2197-2209 (2009)
48. Tamai, H. et al. Activated K-Ras protein accelerates human MLL/AF4-induced leukemo-lymphomogenicity in a transgenic mouse model. Leukemia 25, 888-891 (2011)
49. Bardini, M. et al. Clonal variegation and dynamic competition of leukemia-initiating cells in infant acute lymphoblastic leukemia with MLL rearrangement. Leukemia 29, 38-50 (2015)
50. Ding, L. et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464, 999-1005 (2010)
51. Mardis, E.R. et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 361, 1058-1066 (2009)
52. Flicek, P. et al. Ensembl 2011. Nucleic Acids Res. 39, D800-D806 (2011)
53. Benson, D.A., Karsch-Mizrachi, I., Lipman, D.J., Ostell, J. & Sayers, E.W. GenBank. Nucleic Acids Res. 37, D26-D31 (2009)
54. Benson, D.A., Karsch-Mizrachi, I., Lipman, D.J., Ostell, J. & Wheeler, D.L. GenBank. Nucleic Acids Res. 36, D25-D30 (2008)
55. Chen, K. et al. BreakDancer: an algorithm for high-resolution mapping of genomic structural variation. Nat. Methods 6, 677-681 (2009)
56. Trapnell, C. et al. Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat. Biotechnol. 31, 46-53 (2013)
57. Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511-515 (2010)
58. Zhang, J. et al. SNPdetector: a software tool for sensitive and accurate SNP detection. PLOS Comput. Biol. 1, e53 (2005)
59. Koboldt, D.C. et al. VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics 25, 2283-2285 (2009)
60. Rozen, S. & Skaletsky, H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132, 365-386 (2000)
61. Berman, H.M. The Protein Data Bank: a historical perspective. Acta Crystallogr. A 64, 88-95 (2008)
62. Griffith, J. et al. The structural basis for autoinhibition of FLT3 by the juxtamembrane domain. Mol. Cell 13, 169-178 (2004)
63. Schymkowitz, J. et al. The FoldX web server: an online force field. Nucleic Acids Res. 33, W382-W388 (2005)
64. Mandelker, D. et al. A frequent kinase domain mutation that changes the interaction between PI3K and the membrane. Proc. Natl. Acad. Sci. USA 106, 16996-17001 (2009)
65. Ward, J.J., Sodhi, J.S., McGuffin, L.J., Buxton, B.F. & Jones, D.T. Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. J. Mol. Biol. 337, 635-645 (2004)
66. Gray, R.J. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann. Stat. 16, 1141-1154 (1988)
67. Kalbfleisch, J.D. & Prentice,, R.L. The Statistical Analysis of Failure Time Data (Wiley, 1980)
68. Pounds, S. et al. A genomic random interval model for statistical analysis of genomic lesion data. Bioinformatics 29, 2088-2095 (2013).